«Neuron23»
Neuron23
Companies
Neuron23 is a developer of drugs intended to treat Parkinson's disease and Alzheimer's disease.
Investors
Acorn Bioventures
Cowen Healthcare Investments
HBM Healthcare Investments AG
HBM Partners
Kleiner Perkins
Perceptive Advisors
Redmile Group
SoftBank Vision Fund
Surveyor Capital
Westlake Village BioPartners
Industry:
Global Health Challenges
Headquarters:
United States
Visit Website
Register and Claim Ownership